1. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. (24th March 2022) Authors: Challapalli, A.; Watkins, S.; Cogill, G.; Stewart, G.; Ellis, S.; Sykes, A.; Nobes, J.; Yip, K.; Barthakur, U.; Board, R.; Gadve, A.; O'Toole, L.; Kent, C.; Mackenzie, J.; Papa, S.; Fusi, A.; Fife, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 7(2022) Page Start: e590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The peninsula multicentre head and neck cancer audit: time from surgery to adjuvant radiotherapy. (June 2016) Authors: Mant, S.; Chiu, K.J.; Norris, T.; Fraser, I.; Collinson, M.; Roy, A.; Cogill, G.; Hamilton, C.; Hwang, D. Journal: Clinical oncology Issue: Volume 28(2016)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗